Concepedia
5
Publications
687
Citations
H-Index
2006
Active since
Affiliations
University of Michigan(Current)
ProNAi Therapeutics (United States)
South Texas Accelerated Research Therapeutics
Michael J. Woolliscroft is an author at University of Michigan.
Publications per year
2006–2014
Vascular Targeted Nanoparticles for Imaging and Treatment of Brain Tumors
G. Ramachandra Reddy, Mahaveer S. Bhojani, Patrick McConville et al. · Clinical Cancer Research · 2006 · 484 citations · Full text
A phase 1 study of the BCL2-targeted deoxyribonucleic acid inhibitor (DNAi) PNT2258 in patients with advanced solid tumors
Anthony W. Tolcher, Wendi V. Rodrigueza, Drew Rasco et al. · Cancer Chemotherapy and Pharmacology · 2013 · 87 citations · Full text
Magnetic Resonance Imaging Determination of Tumor Grade and Early Response to Temozolomide in a Genetically Engineered Mouse Model of Glioma
Patrick McConville, Dolores Hambardzumyan, Jonathan B. Moody et al. · Clinical Cancer Research · 2007 · 76 citations
Development and antitumor activity of a BCL-2 targeted single-stranded DNA oligonucleotide
Wendi V. Rodrigueza, Michael J. Woolliscroft, Abdul-Shukkur Ebrahim et al. · Cancer Chemotherapy and Pharmacology · 2014 · 25 citations · Full text
The BCL2 Targeted Deoxyribonucleic Acid Inhibitor (DNAi) PNT2258 Is Active in Patients with Relapsed or Refractory Non-Hodgkin’s Lymphoma
Wael A. Harb, Nehal J. Lakhani, Ana Logsdon et al. · Blood · 2014 · 15 citations
Rows per page
1–5 of 5